inv(16)/t(16;16) acute myeloid leukemia with non–type A CBFB-MYH11 fusions associate with distinct clinical and genetic features and lack KIT mutations
Open Access
- 10 January 2013
- journal article
- Published by American Society of Hematology in Blood
- Vol. 121 (2), 385-391
- https://doi.org/10.1182/blood-2012-07-442772
Abstract
The inv(16)(p13q22)/t(16;16)(p13;q22) in acute myeloid leukemia results in multiple CBFB-MYH11 fusion transcripts, with type A being most frequent. The biologic and prognostic implications of different fusions are unclear. We analyzed CBFB-MYH11 fusion types in 208 inv(16)/t(16;16) patients with de novo disease, and compared clinical and cytogenetic features and the KIT mutation status between type A (n = 182; 87%) and non–type A (n = 26; 13%) patients. At diagnosis, non–type A patients had lower white blood counts (P = .007), and more often trisomies of chromosomes 8 (P = .01) and 21 (P < .001) and less often trisomy 22 (P = .02). No patient with non–type A fusion carried a KIT mutation, whereas 27% of type A patients did (P = .002). Among the latter, KIT mutations conferred adverse prognosis; clinical outcomes of non–type A and type A patients with wild-type KIT were similar. We also derived a fusion-type–associated global gene-expression profile. Gene Ontology analysis of the differentially expressed genes revealed—among others—an enrichment of up-regulated genes involved in activation of caspase activity, cell differentiation and cell cycle control in non–type A patients. We conclude that non–type A fusions associate with distinctclinical and genetic features, including lack of KIT mutations, and a unique gene-expression profile.Keywords
This publication has 40 references indexed in Scilit:
- RUNX1 Mutations Are Associated With Poor Outcome in Younger and Older Patients With Cytogenetically Normal Acute Myeloid Leukemia and With Distinct Gene and MicroRNA Expression SignaturesJournal of Clinical Oncology, 2012
- Age-Related Prognostic Impact of Different Types of DNMT3A Mutations in Adults With Primary Cytogenetically Normal Acute Myeloid LeukemiaJournal of Clinical Oncology, 2012
- KIT with D816 mutations cooperates with CBFB-MYH11 for leukemogenesis in miceBlood, 2012
- Congenital Thrombocytopenia and CytochromecMutation: A Matter of Birth and DeathSeminars in Thrombosis and Hemostasis, 2011
- Recent advances in the understanding and management of MYH9‐related inherited thrombocytopeniasBritish Journal of Haematology, 2011
- A variant allele of Growth Factor Independence 1 (GFI1) is associated with acute myeloid leukemiaBlood, 2010
- Advances in molecular genetics and treatment of core-binding factor acute myeloid leukemiaCurrent Opinion in Oncology, 2008
- Rare CBFB-MYH11 fusion transcripts in AML with inv(16)/t(16;16) are associated with therapy-related AML M4eo, atypical cytomorphology, atypical immunophenotype, atypical additional chromosomal rearrangements and low white blood cell count: a study on 162 patientsLeukemia, 2007
- BiNGO: a Cytoscape plugin to assess overrepresentation of Gene Ontology categories in Biological NetworksBioinformatics, 2005
- TrueLeukemia, 1999